It's Gallbladder and Bile Cancer Awareness Month. These cancers are rare (12,530 cases in 2024) but often diagnosed late due to vague symptoms, resulting in lower survival rates. For example, the 5-year survival rate for gallbladder cancer ranges from 4% at an advanced stage to 68% when localized. In 2024, there were 4,530 deaths from these cancers. In November 2024, the FDA granted accelerated approval for a new drug to treat advanced bile duct cancer and other biliary tract cancers with high HER2 levels that don't respond to chemotherapy. Our clinical trial imaging expertise continues to support treatment and survival in these cancers, and we're proud to see the industry advancing with new treatments. Connect with us at [email protected] to learn more! #CancerAwareness #GallbladderCancer #BileDuctCancer #CancerResearch #clinicaltrials #imaging
